-
Something wrong with this record ?
Sulfated Glucuronorhamnoxylan from Capsosiphon fulvescens Ameliorates Osteoporotic Bone Resorption via Inhibition of Osteoclastic Cell Differentiation and Function In Vitro and In Vivo
SC. Kim, HJ. Kim, GE. Park, CW. Lee, A. Synytsya, P. Capek, YI. Park
Language English Country United States
Document type Journal Article
NLK
ProQuest Central
from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 1999-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1999-01-01 to 1 year ago
- MeSH
- Cell Differentiation MeSH
- Chlorophyta * metabolism MeSH
- TNF Receptor-Associated Factor 6 metabolism MeSH
- Focal Adhesion Kinase 2 metabolism MeSH
- Gelsolin metabolism MeSH
- Tartrate-Resistant Acid Phosphatase metabolism MeSH
- Mice MeSH
- NF-kappa B metabolism MeSH
- Osteoporosis * drug therapy MeSH
- Bone Resorption * drug therapy MeSH
- Sulfates metabolism MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Excessive osteoclast differentiation and/or bone resorptive function causes a gradual loss of bone, leading to the pathogenesis of bone diseases such as osteoporosis (OP). In this study, a sulfated glucuronorhamnoxylan polysaccharide (designated SPS-CF) of the green alga Capsosiphon fulvescens was evaluated for anti-osteoporotic activity using osteoclastic cells differentiated from RAW264.7 macrophages by receptor activator of NF-κB ligand (RANKL) treatment and ovariectomized (OVX) female mice as a postmenopausal OP model. With negligible cytotoxicity, SPS-CF (50 μg/mL) significantly suppressed tartrate-resistant acid phosphatase (TRAP) activity, actin ring formation, and expression of matrix metalloproteinase 9 (MMP-9), cathepsin K, TRAF6, p-Pyk2, c-Cbl, c-Src, gelsolin, carbonic anhydrase II (CA II), and integrin β3, indicating that SPS-CF inhibits the differentiation and bone resorptive function of osteoclasts. Removal of sulfate groups from SPS-CF abolished its anti-osteoclastogenic activities, demonstrating that sulfate groups are critical for its activity. Oral administration of SPS-CF (400 mg/kg/day) to OVX mice significantly augmented the bone mineral density (BMD) and serum osteoprotegerin (OPG)/RANKL ratio. These results demonstrated that SPS-CF exerts significant anti-osteoporotic activity by dampening osteoclastogenesis and bone resorption via downregulation of TRAF6-c-Src-Pyk2-c-Cbl-gelsolin signaling and augmentation of serum OPG/RANKL ratios in OVX mice, suggesting that SPS-CF can be a novel anti-osteoporotic compound for treating postmenopausal OP.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22025078
- 003
- CZ-PrNML
- 005
- 20221031101146.0
- 007
- ta
- 008
- 221017s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10126-022-10136-w $2 doi
- 035 __
- $a (PubMed)35796894
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kim, Seong Cheol $u Department of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon, Gyeonggi-do, 14662, Republic of Korea
- 245 10
- $a Sulfated Glucuronorhamnoxylan from Capsosiphon fulvescens Ameliorates Osteoporotic Bone Resorption via Inhibition of Osteoclastic Cell Differentiation and Function In Vitro and In Vivo / $c SC. Kim, HJ. Kim, GE. Park, CW. Lee, A. Synytsya, P. Capek, YI. Park
- 520 9_
- $a Excessive osteoclast differentiation and/or bone resorptive function causes a gradual loss of bone, leading to the pathogenesis of bone diseases such as osteoporosis (OP). In this study, a sulfated glucuronorhamnoxylan polysaccharide (designated SPS-CF) of the green alga Capsosiphon fulvescens was evaluated for anti-osteoporotic activity using osteoclastic cells differentiated from RAW264.7 macrophages by receptor activator of NF-κB ligand (RANKL) treatment and ovariectomized (OVX) female mice as a postmenopausal OP model. With negligible cytotoxicity, SPS-CF (50 μg/mL) significantly suppressed tartrate-resistant acid phosphatase (TRAP) activity, actin ring formation, and expression of matrix metalloproteinase 9 (MMP-9), cathepsin K, TRAF6, p-Pyk2, c-Cbl, c-Src, gelsolin, carbonic anhydrase II (CA II), and integrin β3, indicating that SPS-CF inhibits the differentiation and bone resorptive function of osteoclasts. Removal of sulfate groups from SPS-CF abolished its anti-osteoclastogenic activities, demonstrating that sulfate groups are critical for its activity. Oral administration of SPS-CF (400 mg/kg/day) to OVX mice significantly augmented the bone mineral density (BMD) and serum osteoprotegerin (OPG)/RANKL ratio. These results demonstrated that SPS-CF exerts significant anti-osteoporotic activity by dampening osteoclastogenesis and bone resorption via downregulation of TRAF6-c-Src-Pyk2-c-Cbl-gelsolin signaling and augmentation of serum OPG/RANKL ratios in OVX mice, suggesting that SPS-CF can be a novel anti-osteoporotic compound for treating postmenopausal OP.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a resorpce kosti $x farmakoterapie $7 D001862
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 12
- $a Chlorophyta $x metabolismus $7 D000460
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fokální adhezní kinasa 2 $x metabolismus $7 D051418
- 650 _2
- $a gelsolin $x metabolismus $7 D018260
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a NF-kappa B $x metabolismus $7 D016328
- 650 12
- $a osteoporóza $x farmakoterapie $7 D010024
- 650 _2
- $a sírany $x metabolismus $7 D013431
- 650 _2
- $a faktor 6 asociovaný s receptory TNF $x metabolismus $7 D048029
- 650 _2
- $a kyselá fosfatasa rezistentní k tartarátu $x metabolismus $7 D000071681
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kim, Hyeon Jeong $u Department of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon, Gyeonggi-do, 14662, Republic of Korea
- 700 1_
- $a Park, Gi Eun $u Department of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon, Gyeonggi-do, 14662, Republic of Korea
- 700 1_
- $a Lee, Chang Won $u Department of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon, Gyeonggi-do, 14662, Republic of Korea
- 700 1_
- $a Synytsya, Andriy $u Department of Carbohydrate Chemistry and Technology, University of Chemistry and Technology in Prague, Technická 5, 166 28, Prague, 6, Czech Republic
- 700 1_
- $a Capek, Peter $u Institute of Chemistry, Centre for Glycomics, Slovak Academy of Sciences, Dúbravská cesta 9, 845 38, Bratislava, Slovakia
- 700 1_
- $a Park, Yong Il $u Department of Biotechnology, Graduate School, The Catholic University of Korea, Bucheon, Gyeonggi-do, 14662, Republic of Korea. yongil382@catholic.ac.kr $u Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, Gyeonggi-do, 14662, Republic of Korea. yongil382@catholic.ac.kr $1 https://orcid.org/http://orcid.org/0000000217490689
- 773 0_
- $w MED00005772 $t Marine biotechnology $x 1436-2236 $g Roč. 24, č. 4 (2022), s. 690-705
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35796894 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031101143 $b ABA008
- 999 __
- $a ok $b bmc $g 1854673 $s 1176368
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 24 $c 4 $d 690-705 $e 20220707 $i 1436-2236 $m Marine biotechnology $n Mar Biotechnol (NY) $x MED00005772
- LZP __
- $a Pubmed-20221017